ストックスクリーナーアプリを入手
99.18
0.68%
-0.68
アフターアワーズ：
99.45
0.27
+0.27%
Merck Co Inc (MRK) 最新ニュース
Hedge Funds Bet Big On Merck & Co. (MRK): Top Healthcare Stock to Watch - Insider Monkey
M Holdings Securities Inc. Lowers Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Boosted by Kingsview Wealth Management LLC - MarketBeat
Cerity Partners LLC Boosts Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Great Valley Advisor Group Inc. - MarketBeat
Landscape Capital Management L.L.C. Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck recommends rejection of TRC Capital’s 'mini-tender' offer - Seeking Alpha
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer - Business Wire
Merck & Co., Inc. (NYSE:MRK) Trading 1.3% HigherHere's What Happened - MarketBeat
Icon Wealth Advisors LLC Has $2.76 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: Emerson Electric CEO to join board - Marketscreener.com
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know - Yahoo Finance
Merck: green light for Welireg in China for VHL disease - Marketscreener.com
Raymond James Trust N.A. Acquires 6,171 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck's Chief Medical Officer to Present at Evercore ISI HealthCONx Conference | MRK Stock News - StockTitan
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by LPL Financial LLC - MarketBeat
Surendralal Karsanbhai Elected to Merck Board of Directors - Business Wire
Goldman Sachs: Merck & Co., Inc. (MRK) Is A Top Growth Investor Stock - Insider Monkey
Exclusive-US FDA finds widely used asthma drug impacts the brain - Marketscreener.com
The Zacks Analyst Blog Highlights Broadcom, Merck, Qualcomm and Natural Health - Yahoo Finance
Top Analyst Reports for Broadcom, Merck & Qualcomm - Yahoo Finance
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Shares Up 0.3%Should You Buy? - MarketBeat
Merck & Co., Inc. (NYSE:MRK) is HealthInvest Partners AB's 3rd Largest Position - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
L & S Advisors Inc Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Holdings Cut by Mizuho Securities USA LLC - MarketBeat
Merck: to present its advances in hematology at ASH - Marketscreener.com
Massachusetts Financial Services Co. MA Sells 1,077,746 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Integrated Investment Consultants LLC - MarketBeat
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Trustmark National Bank Trust Department - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 142,958 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Intech Investment Management LLC Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
King Luther Capital Management Corp Purchases 44,795 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Citizens Financial Group Inc. RI Has $27.79 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ontario Teachers Pension Plan Board Sells 7,664 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jennison Associates LLC Sells 728,756 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care - Yahoo Finance
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio - Insider Monkey
Payden & Rygel Grows Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Moran Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Grandfield & Dodd LLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Sells 792,148 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Commerce Bank Buys 29,422 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Private Wealth LLC Buys 12,781 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Cut by Northwest Bancshares Inc. - MarketBeat
Strategy Asset Managers LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Cut by Quest Partners LLC - MarketBeat
Merck says Keytruda injection on par with approved IV version in trial - Reuters
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co.’s Subcutaneous Keytruda Matches I.V. - Citeline News & Insights
Merck & Co., Inc. (NYSE:MRK) Raises Dividend to $0.81 Per Share - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.1%Here's Why - MarketBeat
Merck readies new Keytruda version ahead of major regulatory headwinds - Seeking Alpha
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients - Yahoo Finance
Merck & Co. Raises Quarterly Dividend by 5.2% - Marketscreener.com
Merck Increases Quarterly Dividend to $0.81 Per Share, Payable Jan. 8 to Shareholders of Record Dec. 16 - Marketscreener.com
Merck Declares $0.81 Per Share Q1 2025 Dividend, Sets January Payment Date | MRK Stock News - StockTitan
New Millennium Group LLC Has $1.27 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
PNC Financial Services Group Inc. Sells 124,005 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New $42.43 Million Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: success of a subcutaneous version of Keytruda - Marketscreener.com
Fifth Third Wealth Advisors LLC Buys 34,312 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Financial Services Inc Purchases 9,387 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Boosted by Smead Capital Management Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Merck stock gains on injectable Keytruda trial win (MRK:NYSE) - Seeking Alpha
Pathstone Holdings LLC Sells 7,059 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Belmont Capital LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’ - Insider Monkey
0.41%
0.21%
大文字化:
|
ボリューム (24 時間):